A multi-modality radiomics-based model for predicting recurrence in non-small cell lung cancer

被引:3
|
作者
Christie, Jaryd R. [1 ,2 ]
Abdelrazek, Mohamed [3 ]
Lang, Pencilla [2 ,4 ]
Mattonen, Sarah A. [1 ,2 ,4 ]
机构
[1] Western Univ, Dept Med Biophys, London, ON, Canada
[2] London Reg Canc Program, Baines Imaging Res Lab, London, ON, Canada
[3] Western Univ, Dept Med Imaging, London, ON, Canada
[4] Western Univ, Dept Oncol, London, ON, Canada
来源
MEDICAL IMAGING 2021: BIOMEDICAL APPLICATIONS IN MOLECULAR, STRUCTURAL, AND FUNCTIONAL IMAGING | 2021年 / 11600卷
关键词
Machine learning; radiomics; lung cancer; segmentation; quantitative imaging; outcome prediction; SURVIVAL; FEATURES; CANADA; TUMOR;
D O I
10.1117/12.2586233
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Non-small cell lung cancer (NSCLC) is one of the leading causes of death worldwide. Medical imaging is used to determine cancer staging; however, these images may hold additional information which could be utilized to aid in outcome prediction. A multi-modality radiomics approach incorporating quantitative and qualitative features from the tumor and its surrounding regions, along with clinical features, has yet to be explored. Therefore, we hypothesize that a model containing CT and PET radiomic features, in addition to clinical and qualitative features, has the potential improve risk-stratification of NSCLC patients better than cancer stage alone. Our dataset consisted of 135 NSCLC patients (training: n=94, testing: n=41) who underwent surgical resection. Each region of interest was segmented using a semi-automatic approach on both the pre-treatment CT and PET images. Radiomic features were extracted using the Quantitative Image Feature Engine. A total of 1030 features were extracted including clinical, qualitative, and radiomic features. LASSO regression was used to identify the top features to predict time to recurrence in the training cohort and the model was evaluated in the testing cohort. A total of nine features were selected, including two clinical, one CT, and six PET radiomic features. The model achieved a concordance of 0.81 in the training cohort, which was validated in the testing cohort (concordance=0.79) and outperformed stage alone (concordances=0.68-0.69). This model has the potential to assist physicians in risk-stratifying patients with NSCLC and could be used to identify patients that may benefit from more aggressive or personalized treatment options.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Radiomics-based predictive risk score: A scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer
    Lan He
    Yanqi Huang
    Lixu Yan
    Junhui Zheng
    Changhong Liang
    Zaiyi Liu
    ChineseJournalofCancerResearch, 2019, 31 (04) : 641 - 652
  • [32] Robust Identification of Subtypes in Non-Small Cell Lung Cancer Using Radiomics
    Wang, Ke
    An, Ying
    Li, Ni
    Zhou, Jiancun
    Chen, Xianlai
    TRAITEMENT DU SIGNAL, 2022, 39 (04) : 1399 - 1406
  • [33] Radiomics-Clinical AI Model with Probability Weighted Strategy for Prognosis Prediction in Non-Small Cell Lung Cancer
    Tang, Fuk-Hay
    Fong, Yee-Wai
    Yung, Shing-Hei
    Wong, Chi-Kan
    Tu, Chak-Lap
    Chan, Ming-To
    BIOMEDICINES, 2023, 11 (08)
  • [34] Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer
    Chen, Qiaoling
    Shao, JingJing
    Xue, Ting
    Peng, Hui
    Li, Manman
    Duan, Shaofeng
    Feng, Feng
    EUROPEAN RADIOLOGY, 2023, 33 (02) : 947 - 958
  • [35] Development and validation of multi-sequence magnetic resonance imaging radiomics models for predicting tumor response to radiotherapy in locally advanced non-small cell lung cancer
    Liu, Shangqun
    Lv, Yan
    Duan, Liwen
    Wang, Chengcheng
    Wang, Helong
    Hu, Songliu
    Abbar, Baptiste
    Xu, Jianyu
    JOURNAL OF THORACIC DISEASE, 2025, : 1684 - 1697
  • [36] Radiomics nomogram for predicting chemo-immunotherapy efficiency in advanced non-small cell lung cancer
    Jin, Hua
    Wang, Yuchao
    Li, Xushuo
    Yang, Ying
    Qi, Ruixue
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [37] A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer
    Chen, Xin
    Fang, Mengjie
    Dong, Di
    Wei, Xinhua
    Liu, Lingling
    Xu, Xiangdong
    Jiang, Xinqing
    Tian, Jie
    Liu, Zaiyi
    ACADEMIC RADIOLOGY, 2018, 25 (12) : 1548 - 1555
  • [38] Prognostic Value and Pathological Correlation of Peritumoral Radiomics in Surgically Resected Non-Small Cell Lung Cancer
    Tominaga, Masaki
    Yamazaki, Motohiko
    Umezu, Hajime
    Sugino, Hideaki
    Fuzawa, Yuma
    Yagi, Takuya
    Ishikawa, Hiroyuki
    ACADEMIC RADIOLOGY, 2024, 31 (09) : 3801 - 3810
  • [39] Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer
    Shi, Liting
    He, Yaoyao
    Yuan, Zilong
    Benedict, Stanley
    Valicenti, Richard
    Qiu, Jianfeng
    Rong, Yi
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [40] Diagnosis of Non-Small Cell Lung Cancer Using Phylogenetic Diversity in Radiomics Context
    Neto, Antonino C. dos S.
    Diniz, Pedro H. B.
    Diniz, Joao O. B.
    Cavalcante, Andre B.
    Silva, Aristofanes C.
    de Paiva, Anselmo C.
    de Almeida, Joao D. S.
    IMAGE ANALYSIS AND RECOGNITION (ICIAR 2018), 2018, 10882 : 598 - 604